Doctor’s Sales Slip-Up: Five‑Month Suspension & $2,000 Fine
In Singapore, a routine do‑soon‑to‑be‑obsolete pharmaceutical transaction turned into a courtroom drama when Dr. Ho Tze Woon attempted to sell a bottle of Cialis—a regulated erectile dysfunction drug— to a man who was not his patient. Though the deal never sealed (the man rejected the damaged packaging), the Singapore Medical Council (SMC) decided it was more than a simple misstep: it was a blatant abuse of a doctor’s privileged status.
What the Tribunal Saw
- The attempt to sell Cialis was a two‑fold offense.
- A thirteenth accusation (unproceeded) involved downloading adult material onto consultation‑room computers.
- Dr. Ho pleaded guilty, citing that the drug was “not addictive” and he was merely helping the man save money.
- He was suspended for five months and fined $2,000—plus a public censure and an order to pay the cost of the proceedings.
The Deal Averted (and Why It Still Matters)
During their first run, the guy refused the Cialis because the packaging was compromised. On the second attempt, negotiations stalled over price: Dr. Ho quoted $203 for a 28‑pills box, including GST. The ensuing text‑message exchange (excerpted below) shows a very clear business‑first motive:
Mr. C: “Btw, why r u charging GST?”
Dr. Ho: “Not me, it’s supplier.”
Mr. C: “Supplier? I’m not even getting a receipt!”
Mr. C: “Like this it’s not much diff from buying from clinic!”
Dr. Ho: “Ok 190 is ok. U coming or not?”
Mr. C: “Otw. $180?”
The tribunal concluded that this transactional ambition—despite its failure—clearly affronted medical ethics. The fact that the sale never happened does not erase the abuse of trust in the profession.
Why This Is a Big Deal
- Doctors are granted the privilege to dispense drugs under the Poison Act, but only for genuine patient care.
- Such incidents erode public confidence, turning a steadfast disclaimer (“doctors do this for patients”) into a consultation room conspiracy.
- It may be the first disciplinary case of its kind—highlighting how the regulatory framework is tightening around non‑patient prescriptions.
Final Verdict
On June 1st, the SMC’s verdict became public: Dr. Ho faces a five‑month suspension and a monetary penalty of $2,000. While the drug never changed hands, the intent—evidenced through text messaging—remains clear: a cynical attempt to profit under the guise of patient care.
For the sake of patients, the medical profession will hopefully steer clear of “off‑label” deals in the future—lest the next bottle of Cialis find itself in a courtroom instead of a pharmacy shelf.
